SAN DIEGO, Aug. 28, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data on now FDA-approved INGREZZA® (valbenazine) capsules for the treatment of adults with ...
In a study on treatments and outcomes in patients with Sydenham chorea (SC), corticosteroids were associated with faster resolution, while antibiotics, corticosteroids, and sodium valproate were ...
Sydenham's chorea (SC) is a neurological disorder characterized by involuntary movements and is often associated with rheumatic fever, particularly in children. It is considered an immune-mediated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback